{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:16:54Z","timestamp":1761675414608},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mce.2006.02.021","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T12:30:00Z","timestamp":1162989000000},"page":"237-243","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Hyperglycosylated HCG expression in pregnancy: Cellular origin and clinical applications"],"prefix":"10.1016","volume":"260-262","author":[{"given":"G.","family":"Kovalevskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schlatterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2006.02.021_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0021-9258(19)57280-5","article-title":"Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women","volume":"263","author":"Amano","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.ajog.2005.03.021","article-title":"Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies","volume":"192","author":"Avgidou","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2006.02.021_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1067\/mob.2000.108884","article-title":"Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies","volume":"183","author":"Bahado-Singh","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2006.02.021_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000086484","article-title":"Specific measurement of O-linked core 2 sugar-containing isoforms of hyperglycosylated human chorionic gonadotropin by antibody B152","volume":"26","author":"Birken","year":"2005","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mce.2006.02.021_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/ENDO:10:2:137","article-title":"Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG","volume":"10","author":"Birken","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2006.02.021_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0303-7207(03)00153-9","article-title":"Analysis of human choriogonadotropin core 2 O-glycan isoforms","volume":"204","author":"Birken","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2006.02.021_bib7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/clinchem\/47.12.2131","article-title":"Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices","volume":"47","author":"Butler","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j..2004.00177.x","article-title":"Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers","volume":"65","author":"Christiansen","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mce.2006.02.021_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-65-4-811","article-title":"The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma HCG","volume":"65","author":"Cole","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2006.02.021_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajog.2003.08.043","article-title":"Accuracy of home pregnancy tests at the time of missed menses","volume":"190","author":"Cole","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2006.02.021_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(03)00108-5","article-title":"Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection","volume":"36","author":"Cole","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mce.2006.02.021_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/(SICI)1097-0223(199809)18:9<926::AID-PD377>3.0.CO;2-F","article-title":"Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening","volume":"18","author":"Cole","year":"1998","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib13","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening","volume":"45","author":"Cole","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<351::AID-PD546>3.0.CO;2-X","article-title":"Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG","volume":"19","author":"Cole","year":"1999","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/(SICI)1097-0223(199910)19:10<918::AID-PD680>3.0.CO;2-4","article-title":"Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome","volume":"19","author":"Cuckle","year":"1999","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/molehr\/2.9.643","article-title":"More in vitro bioactive, shorter-lived human chorionic gonadotrophin charge isoforms increase at the end of the first and during the third trimesters of gestation","volume":"2","author":"Diaz-Cueto","year":"1996","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mce.2006.02.021_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1369\/jhc.4B6420.2005","article-title":"First-trimester screening: an overview","volume":"53","author":"Eiben","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mce.2006.02.021_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02778058","article-title":"Carbohydrate and peptide structure of the alpha and beta subunits of chorionic gonadotropin (hCG): characteristics and variants in 32 subunit preparations from normal and aberrant pregnancy and choriocarcinoma","volume":"7","author":"Elliott","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2006.02.021_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/HUMREP\/11.2.406","article-title":"A prospective study of early pregnancy loss","volume":"11","author":"Ellish","year":"1996","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2006.02.021_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/1097-0223(200010)20:10<785::AID-PD892>3.0.CO;2-6","article-title":"First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG","volume":"20","author":"Hallahan","year":"2000","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-0223(199803)18:3<235::AID-PD248>3.0.CO;2-A","article-title":"hCG and the free beta-subunit as screening tests for Down syndrome","volume":"18","author":"Knight","year":"1998","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0925-4439(99)00060-5","article-title":"Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin","volume":"1455","author":"Kobata","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2006.02.021_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1677\/joe.0.1610099","article-title":"Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG","volume":"161","author":"Kovalevskaya","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2006.02.021_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/joe.0.1720497","article-title":"Differential expression of hCG glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope","volume":"172","author":"Kovalevskaya","year":"2002","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2006.02.021_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(02)00135-1","article-title":"Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG","volume":"194","author":"Kovalevskaya","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2006.02.021_bib26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.mce.2006.02.021_bib27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2006.02.021_bib28","doi-asserted-by":"crossref","first-page":"12068","DOI":"10.1074\/jbc.273.20.12068","article-title":"Developmental changes in the glycosylation of glycoprotein hormone free alpha subunit during pregnancy","volume":"273","author":"Nemansky","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/uog.1860","article-title":"Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening","volume":"25","author":"Nicolaides","year":"2005","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.mce.2006.02.021_bib30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/endo-123-1-420","article-title":"Fragmentation of the beta-subunit of human chorionic gonadotropin produced by choriocarcinoma","volume":"123","author":"Nishimura","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2006.02.021_bib31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z","article-title":"Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss","volume":"18","author":"O\u2019Connor","year":"1998","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib32","first-page":"650","article-title":"Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements","volume":"15","author":"O\u2019Connor","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2006.02.021_bib33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2005.050567","article-title":"Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening","volume":"51","author":"Palomaki","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib34","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1373\/clinchem.2004.038059","article-title":"Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester","volume":"50","author":"Palomaki","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1373\/clinchem.2004.032839","article-title":"Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening","volume":"50","author":"Pandian","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib36","first-page":"91","article-title":"Glycosylation changes in human chorionic gonadotropin and free alpha subunit as gestation progresses","volume":"75","author":"Skarulis","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2006.02.021_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-0223(200004)20:4<311::AID-PD809>3.0.CO;2-P","article-title":"Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib38","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/1097-0223(200012)20:12<976::AID-PD962>3.0.CO;2-2","article-title":"Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities","volume":"20","author":"Weinans","year":"2000","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.mce.2006.02.021_bib39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1373\/clinchem.2005.048751","article-title":"Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) as a first-trimester serum marker for Down syndrome","volume":"51","author":"Weinans","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2006.02.021_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/acta.0.1160465","article-title":"Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic diseases","volume":"116","author":"Wide","year":"1987","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.mce.2006.02.021_bib41","first-page":"1419","article-title":"A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation","volume":"78","author":"Wide","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720706004886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720706004886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T15:03:28Z","timestamp":1628089408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720706004886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":41,"alternative-id":["S0303720706004886"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2006.02.021","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}